TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsFour Chinese pharmaceutical firms to invest in Indonesia, BKPM says
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Investment Coordinating Board (BKPM) chairman Franky Sibarani speaks at a business forum in Berlin on April 18, promising more opportunities for investment in Indonesia will be created by a streamlining of bureaucratic procedures. (KONTAN/Cheppy A Muchlis)
T
he Investment Coordinating Board (BKPM) has announced it will assist four China-based pharmaceutical companies to invest in Indonesia.
Without revealing the companies’ names, BKPM chairman Franky Sibarany said the four have gathered detailed information on the latest regulations in the industry, including foreign ownership and other supporting regulations.
“I positively welcome the Chinese companies’ interest in investing, especially as the government is pushing efforts to develop the pharmaceutical and medical equipment industry in the country," he said in a press statement on Sunday.
The government is working on a road map and work plan for developing the pharmaceutical and medical equipment industry.
As a national health-insurance program has been running, Franky elaborated, the need for medicine and medical equipment would potentially rise to support the state insurance scheme.
"President Joko Widodo expects that the portion of the locally manufactured raw materials for medicine to reach 50 percent by 2019," he said. (ags)
